Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MENPI
2024-516961-35-01Phase 4Authorised
- Sponsor
- Copenhagen University Hospital - Hvidovre
- Start
- Oct 2024
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of meningococcal vaccine (SPbSRIVS) in meningococcal disease and pneumococcal disease, sponsored by Copenhagen University Hospital - Hvidovre. Planned start Oct 2024; status: authorised.
02
Drugs
meningococcal vaccine (SPbSRIVS)
03
Conditions
meningococcal diseasepneumococcal disease
Beyond the preview
Go deeper on 2024-516961-35-01.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-516961-35-01.